For RFS of patients with ovarian cancer, SPOCK2 and FAXDC2 were unfavorable prognostic biomarkers but ADAMDEC1, CCNA2, FAM181A, FOXA2, LRRTM1, NEIL3 and XPR1 were favorable prognostic biomarkers (Figure 4B). Here, NEIL3 is linked to ovarian cancer.